Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
26.58
-0.08 (-0.30%)
Sep 29, 2026, 4:00 PM EDT - Market closed
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $1.04 billion as of September 29, 2026. Its market cap has increased by 875.25% in one year.
Market Cap
1.04B
Enterprise Value
822.62M
1-Year Change
875.25%
Ranking
Category
Stock Price
$26.58
ChartMarket Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has increased from $528.69M to $1.04B, an increase of 97.29%. That is a compound annual growth rate of 29.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 1.04B | 88.62% |
| Dec 31, 2025 | 552.98M | 384.71% |
| Dec 31, 2024 | 114.08M | -78.42% |
| Feb 2, 2024 | 528.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aktis Oncology | 1.09B |
| Vor Biopharma | 1.09B |
| MannKind | 1.08B |
| Odyssey Therapeutics | 1.07B |
| MeiraGTx Holdings | 1.06B |
| SL Science Holding | 1.05B |
| Janux Therapeutics | 1.03B |
| Seaport Therapeutics | 1.02B |